Myriad Genetics, Inc. (MYGN)
USD 7.72
(-2.4%)
USD 7.72
(-2.4%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 | 20.1 Million USD | 31.37% |
| 2021 | 15.3 Million USD | -43.54% |
| 2020 | 27.1 Million USD | -13.69% |
| 2019 | 31.4 Million USD | 0.0% |
| 2018 | 31.4 Million USD | -8.45% |
| 2017 | 34.3 Million USD | -18.72% |
| 2016 | 42.2 Million USD | 10.18% |
| 2015 | 38.3 Million USD | 52.59% |
| 2014 | 25.1 Million USD | 4.94% |
| 2013 | 23.91 Million USD | 377.71% |
| 2012 | 5 Million USD | -56.74% |
| 2011 | 11.57 Million USD | 104.2% |
| 2010 | 5.66 Million USD | 101.42% |
| 2009 | -399.17 Million USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q3 | 25.1 Million USD | 11.56% |
| 2023 Q1 | 21.8 Million USD | 8.46% |
| 2023 Q2 | 22.5 Million USD | 3.21% |
| 2022 FY | 20.1 Million USD | 31.37% |
| 2022 Q4 | 20.1 Million USD | 2.55% |
| 2022 Q3 | 19.6 Million USD | 27.27% |
| 2022 Q2 | 15.4 Million USD | -1.28% |
| 2022 Q1 | 15.6 Million USD | 1.96% |
| 2021 FY | 15.3 Million USD | -43.54% |
| 2021 Q1 | 24.6 Million USD | -9.23% |
| 2021 Q2 | 17.7 Million USD | -28.05% |
| 2021 Q3 | 18.6 Million USD | 5.08% |
| 2021 Q4 | 15.3 Million USD | -17.74% |
| 2020 FY | 27.1 Million USD | -13.69% |
| 2020 Q1 | 30.8 Million USD | 9.61% |
| 2020 Q3 | 26.6 Million USD | -8.59% |
| 2020 Q2 | 29.1 Million USD | -5.52% |
| 2020 Q4 | 27.1 Million USD | 1.88% |
| 2019 FY | 31.4 Million USD | 0.0% |
| 2019 Q1 | 31.9 Million USD | -4.2% |
| 2019 Q2 | 31.4 Million USD | -1.57% |
| 2019 Q3 | 28.1 Million USD | -10.51% |
| 2019 Q4 | 28.1 Million USD | 0.0% |
| 2018 FY | 31.4 Million USD | -8.45% |
| 2018 Q3 | 35.9 Million USD | 4.66% |
| 2018 Q4 | 33.3 Million USD | -7.24% |
| 2018 Q1 | 33.4 Million USD | -12.57% |
| 2018 Q2 | 34.3 Million USD | 2.69% |
| 2017 Q1 | 47.4 Million USD | -7.6% |
| 2017 FY | 34.3 Million USD | -18.72% |
| 2017 Q2 | 42.2 Million USD | -10.97% |
| 2017 Q3 | 38.9 Million USD | -7.82% |
| 2017 Q4 | 38.2 Million USD | -1.8% |
| 2016 Q4 | 51.3 Million USD | -4.82% |
| 2016 FY | 42.2 Million USD | 10.18% |
| 2016 Q2 | 38.3 Million USD | 51.38% |
| 2016 Q1 | 25.3 Million USD | -13.06% |
| 2016 Q3 | 53.9 Million USD | 40.73% |
| 2015 Q3 | 34.3 Million USD | 36.65% |
| 2015 FY | 38.3 Million USD | 52.59% |
| 2015 Q1 | 29.35 Million USD | 45.54% |
| 2015 Q2 | 25.1 Million USD | -14.51% |
| 2015 Q4 | 29.1 Million USD | -15.16% |
| 2014 Q3 | 24.77 Million USD | 3.58% |
| 2014 Q1 | 18.9 Million USD | 308.35% |
| 2014 Q2 | 23.91 Million USD | 26.52% |
| 2014 Q4 | 20.17 Million USD | -18.58% |
| 2014 FY | 25.1 Million USD | 4.94% |
| 2013 Q2 | 5 Million USD | -29.83% |
| 2013 FY | 23.91 Million USD | 377.71% |
| 2013 Q3 | -8.76 Million USD | -275.11% |
| 2013 Q4 | -9.07 Million USD | -3.49% |
| 2013 Q1 | 7.13 Million USD | -31.82% |
| 2012 Q4 | 10.46 Million USD | -1.27% |
| 2012 Q1 | 10.38 Million USD | 0.86% |
| 2012 Q2 | 11.57 Million USD | 11.47% |
| 2012 Q3 | 10.6 Million USD | -8.4% |
| 2012 FY | 5 Million USD | -56.74% |
| 2011 Q4 | 10.29 Million USD | 6.09% |
| 2011 Q1 | -358.98 Million USD | 7.41% |
| 2011 Q3 | 9.7 Million USD | 71.19% |
| 2011 Q2 | 5.66 Million USD | 101.58% |
| 2011 FY | 11.57 Million USD | 104.2% |
| 2010 Q1 | -395.74 Million USD | 0.0% |
| 2010 FY | 5.66 Million USD | 101.42% |
| 2010 Q4 | -387.7 Million USD | 0.0% |
| 2010 Q3 | - USD | -100.0% |
| 2010 Q2 | 22.61 Million USD | 105.71% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | -399.17 Million USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | -5990.411% |
| Aspira Women's Health Inc. | 227 Thousand USD | -8754.626% |
| Biodesix, Inc. | 1.4 Million USD | -1335.714% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | -1666.614% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -108642.696% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -108642.696% |
| Bionano Genomics, Inc. | 22.89 Million USD | 12.2% |
| CareDx, Inc | 19.47 Million USD | -3.23% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 7.94 Million USD | -153.085% |
| DarioHealth Corp. | 5.06 Million USD | -297.076% |
| Exact Sciences Corporation | 127.47 Million USD | 84.232% |
| Fulgent Genetics, Inc. | 5.82 Million USD | -244.946% |
| Guardant Health, Inc. | 61.94 Million USD | 67.553% |
| ICON Public Limited Company | 1.00 USD | -2009999900.0% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 94.714% |
| Illumina, Inc. | 587 Million USD | 96.576% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -2485.086% |
| iSpecimen Inc. | - USD | -Infinity% |
| Standard BioTools Inc. | 20.53 Million USD | 2.109% |
| MDxHealth SA | 2.77 Million USD | -623.282% |
| 23andMe Holding Co. | 12.46 Million USD | -61.252% |
| Medpace Holdings, Inc. | 1.00 USD | -2009999900.0% |
| Mainz Biomed B.V. | 613.63 Thousand USD | -3175.547% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | -666.338% |
| NeoGenomics, Inc. | 24.15 Million USD | 16.791% |
| Neogen Corporation | 189.26 Million USD | 89.38% |
| Inotiv, Inc. | 56.1 Million USD | 64.172% |
| Natera, Inc. | 40.75 Million USD | 50.686% |
| OpGen, Inc. | 1.00 USD | -2009999900.0% |
| OPKO Health, Inc. | 65.69 Million USD | 69.405% |
| Psychemedics Corporation | 1.00 USD | -2009999900.0% |
| Prenetics Global Limited | 3.12 Million USD | -542.835% |
| Prenetics Global Limited | 3.12 Million USD | -542.835% |
| Precipio, Inc. | 384 Thousand USD | -5134.375% |
| Personalis, Inc. | 5.66 Million USD | -255.061% |
| RadNet, Inc. | 1.00 USD | -2009999900.0% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| Sotera Health Company | 51.98 Million USD | 61.335% |
| Neuronetics, Inc. | 8.09 Million USD | -148.363% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -487.719% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -487.719% |
| Trinity Biotech plc | 19.93 Million USD | -0.838% |
| T2 Biosystems, Inc. | 4.81 Million USD | -317.099% |
| Twist Bioscience Corporation | 32.06 Million USD | 37.311% |
| Exagen Inc. | 2.87 Million USD | -600.104% |